Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is $127, with a 24-hour trading volume of $219.87M. The asset's market cap is $313.67B, after moving -1.84% in the last day.
Tokenized Merck & Co Inc is trading at $128.84, with a tokenized market cap of $42.53M and a 24-hour trading volume of $658.39K. The tokenized asset has moved 1.75% in the past 24 hours.